Seite wählen

Elsevier has entered into an agreement with CRUE-CSIC on behalf of the CRUE-CSIC institutions to provide Spanish researchers with continuous access to reading and open access publications. This agreement helps authors affiliated with member institutions of Spanish institutions to publish their research in open access in Elsevier journals without having to pay an APC. The cost of publishing Open Access is covered by the terms of the agreement. Elsevier has specific publishing agreements with certain governmental and intergovernmental organizations for its employed authors. These agreements allow authors to retain essentially the same rights described in the „Copyright“ section, but are specifically tailored to employees of the relevant organisations, including: Elsevier has an agreement with the VSNU (Association of Universities in the Netherlands), the UKB (Dutch Consortium of University Libraries and the Royal Library), the NWO (Netherlands Organisation for Scientific Research). Research). and the NFU (Dutch Association of Teaching Hospitals). The authors sign an exclusive license agreement in which the authors have the copyright but grant the exclusive rights of their article to the publisher**. In this case, the authors have the right to: This agreement supports the corresponding authors associated with the Spanish participating institutions, regardless of the department in which they work. Authors transfer the copyright to the publisher under a journal publication agreement, but have the right to: * If your original article was submitted before 1.1.2020, it may still be eligible under our prior agreement in the Netherlands.

Once your article has been accepted for publication and you see the Open Access option indicating that your APC is covered by the Agreement, please select the Open Access option. In order for Elsevier to publish and distribute research papers, we need publishing rights. This is determined by a publishing contract between the author and Elsevier. This Agreement deals with the transfer or licensing of copyright to Elsevier and authors retain significant rights to use and share their own published articles. Elsevier supports the need for authors to share, disseminate and maximize the impact of their research, and these rights to Elsevier`s proprietary journals* are defined below: This agreement is in effect until the end of December 2024. We are also able to help researchers comply with the guidelines of their funders and institutions. We have a number of agreements with organisations such as the Wellcome Trust, Research Councils UK that help define compliant open access options for researchers. Consult our list of financing agreements. *Please note that journals owned by the Company or third parties may have different publication agreements. Please refer to the Journal for Authors Guide for copyright information specific to a journal. Copyright aims to protect the specific way the article was written to describe an experiment and the results. Elsevier is committed to protecting and defending their work and reputation, and takes allegations of harm, plagiarism, ethical litigation and fraud very seriously.

. **This includes the publisher`s right to make and authorize commercial use, see „Rights Granted to Elsevier“ for more information. All Gold Open Access items are free for everyone. We may offer Gold Open Access services because the Article Publishing Fee (APC) or other fee paid by the authors, their institutions or funding bodies covers all costs necessary to support the publication process. . Spanish authors can always choose to publish under the subscription model and archive their manuscript themselves (Green Open Access) in accordance with Elsevier`s sharing policy. . Search tool to find the embargo period of your Elsevier newspaper. Millions of researchers have subscriptions to instantly access research on ScienceDirect. In order to allow free access to a subscription item, a delay, called an embargo period, is required.

This starts on the date the article is officially published online in its final and fully citable form (i.e. the date of online publication or the date of publication of the issue). Our embargo periods are usually between 12 and 24 months and specific embargo periods can be found on the homepages of individual journals. Elsevier`s proprietary journals are subject to the following steps: Elsevier CPAs range from $150 to $6,000 tax-free, depending on the journal, with prices clearly displayed on our Article Publishing Fee (APC) price list and on the journal`s home pages. To learn more about how and why we rate items differently, please visit our pricing page. . This is when published research is free for everyone to read and use. Elsevier supports Gold and Green Open Access. To learn more about our approach to open access, visit the links below. If an article was published under the subscription model, it can be shared as follows: Learn more about the benefits of open access publishing on Elsevier by visiting our Open Access Author Hub If you would like information on how to obtain permission for such uses, click here or if you would like to use the article for commercial purposes, please visit the Authorization Support Center. Green Open Access is possible because subscribers bear all the necessary costs to support the publishing process.

This means that authors do not have to pay any additional fees. Here you will find an overview of all open access journals published by Elsevier. Learn more about our open access book publishing options. If the article is published in a journal that contains an open archive, it will be made available after an embargo. Elsevier is a founding member and supports the CHORUS service by offering a cost-effective compliance service for open access. As a result of the White House Office of Science and Technology Policy (OSTP) memorandum, each federal agency is tasked with developing plans to make published results of state-funded research freely available to the public within one year of publication, and for requiring researchers to share digital data derived from publicly funded scientific research. better to consider and manage. In some cases, agencies already have long-established public access policies like the NIH, but most agencies have or will announce new policies. These guidelines will affect how U.S. researchers should publish their results. To comply with U.S.

public access guidelines, we have described below the open access options for U.S. researchers. For subscription and open access articles published in proprietary titles, Elsevier is granted the following rights: This is a version of a subscription article that anyone can access for free. These rights apply to all Elsevier authors who publish their article either as a subscription article or as an open access article. In any case, we require that all Elsevier authors always include full confirmation and, if applicable, a link to the final published version hosted on Science Direct. . Ireland (Consortium of Irish Universities) There are also other ways in which Elsevier can link to articles. For example, if your funder works with CHORUS, all readers can search for your article and follow a link to ScienceDirect, where they can access the final version of the article or the accepted manuscript.

Elsevier provides free access to archival material in select Elsevier journals. If an author becomes aware of any plagiarism, fraud or injury, we recommend that you contact their Elsevier contact, who may then contact our in-house legal department. Note that some open access user licenses may allow for fairly broad reuse, which could otherwise be considered copyright infringement. For more information on how to obtain permission to use an item, please visit our eligibility page. Anyone can download, copy and share Gold Open Access articles. We offer authors the choice of publishing under the Creative Commons CC-BY or Creative Commons CC-BY-NC-ND licenses. These licenses help maximize the impact of your item and make it the most widespread and useful use. Click here for details.

Describes the rights related to the publication and dissemination of research results. .